Cite
HARVARD Citation
Cicmil Saric, N. et al. (n.d.). Impact of subcutaneous versus intravenous administration of pertuzumab and trastuzumab (PH) for the treatment of HER2-positive breast cancer in Montenegro. European journal of cancer. pp. S72-. [Online].